InsidersTradesSigma
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Quinn William P., 首席财务官. Officer active across 1 company, notably Bolt Biotherapeutics, Inc.. Cumulatively, 5 reports have been published. Breakdown: 5 buys · 0 sell. Total volume traded: €21k. Activity tracked since 4 June 2021. The latest transaction was filed on 5 December 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
William P. Quinn is the Chief Financial Officer of Bolt Biotherapeutics, Inc. He is responsible for the financial management of the company, which focuses on developing immuno-oncology therapies.